Both in Pharmaceuticals
Generate Biomedicines vs Xeris Biopharma Holdings
Over the past year GENB returned −9.9% and XERS returned +40.4%; their daily moves had a correlation of 0.37.
GENB −9.9% XERS +40.4%Growth of $1, one year, split-adjusted
| Metric | GENB | XERS |
|---|---|---|
| Price | $14.16 | $10.46 |
| Market cap | $1.82B | $1.91B |
| Today | +2.24% | +1.06% |
| 1 month | +2.6% | +3.9% |
| 6 months | — | +64.2% |
| Year to date | — | +33.2% |
| 1 year | — | +5.7% |
| Revenue growth (YoY) | — | +28.7% |
| Gross margin | 100.0% | 86.4% |
| Net margin | −1065.2% | −33.8% |
| P/E (TTM) | — | — |
| Price / sales | — | 5.7× |
| Net cash | $452.3M | -$130.8M |
| Dividend yield | — | — |
| Volatility (60d) | — | 51.6% |
| Short % of float | 15.4% | 4.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).